Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
EULAR Rheumatology Open|June 29, 2026
Low-dose atovaquone for prophylaxis of Pneumocystis jirovecii pneumonia in patients with connective tissue diseases: an open-label, multicentre, single-arm, phase II trialTomoaki Ida, Shunsuke Furuta, Yosuke Inaba, et al.
The Journal of Experimental Medicine|September 8, 2018
Sox12 promotes T reg differentiation in the periphery during colitisShigeru Tanaka, Akira Suto, Taro Iwamoto, et al.
The Journal of Clinical Psychiatry|November 13, 2009
Acute treatment of pediatric bipolar I disorder, manic or mixed episode, with aripiprazole: a randomized, double-blind, placebo-controlled studyRobert L Findling, Margaretta Nyilas, Robert A Forbes, et al.
Journal of Psychopharmacology (Oxford, England)|January 13, 2006
Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled studyGary Sachs, Raymond Sanchez, Ronald Marcus, et al.
Immunological Medicine|September 11, 2025
Comparison of drug retention rates between TNF inhibitors and tocilizumab for Takayasu arteritis: a multicenter retrospective studyTakahiro Sugiyama, Shunsuke Furuta, Taro Iwamoto, et al.
European Heart Journal|April 24, 2010
Assessment of acute injuries and chronic intimal thickening of the radial artery after transradial coronary intervention by optical coherence tomographyTaishi Yonetsu, Tsunekazu Kakuta, Tetsumin Lee, et al.
The American Journal of Psychiatry|September 4, 2008
A multiple-center, randomized, double-blind, placebo-controlled study of oral aripiprazole for treatment of adolescents with schizophreniaRobert L Findling, Adelaide Robb, Margaretta Nyilas, et al.
RMD Open|January 2, 2023
Efficacy and safety of dose escalation of tofacitinib in refractory anti-MDA5 antibody-positive dermatomyositisTomoaki Ida, Shunsuke Furuta, Asuka Takayama, et al.
Rheumatology (Oxford, England)|March 13, 2013
[18F]FDG uptake in proximal muscles assessed by PET/CT reflects both global and local muscular inflammation and provides useful information in the management of patients with polymyositis/dermatomyositisShigeru Tanaka, Kei Ikeda, Katsuhiro Uchiyama, et al.
Schizophrenia Research|February 18, 2006
A prospective, multicenter, randomized, parallel-group, open-label study of aripiprazole in the management of patients with schizophrenia or schizoaffective disorder in general psychiatric practice: Broad Effectiveness Trial With Aripiprazole (BETA)Rajiv Tandon, Ronald N Marcus, Elyse G Stock, et al.
Pageof 5